Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Colorectal Neoplasms

Free Subscription 06.10.2025 1 Am J Epidemiol 2 Ann Oncol 4 Ann Surg Oncol 6 Anticancer Res 7 BMC Cancer 3 BMC Gastroenterol 2 Br J Cancer 2 Br J Surg 2 Cancer Lett 3 Cancer Res 1 Clin Cancer Res 1 Clin Res Hepatol Gastroenterol 1 Dis Colon Rectum 4 Eur J Cancer 1 Eur J Gastroenterol Hepatol 11 Eur J Surg Oncol 1 Gastrointest Endosc 1 Int J Cancer 2 Int J Colorectal Dis 1 J Clin Oncol 3 J Natl Cancer Inst 1 J Nucl Med 1 J Surg Oncol 1 Oncogene 2 Oncol Rep 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Epidemiol

1. VAN DUUREN LA, Bulliard JL, Harlass M, Plys E, et al
   Risk-based guidance for choosing FIT or colonoscopy in colorectal cancer screening: a modelling study.
   Am J Epidemiol. 2025 Sep 30:kwaf214. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Oncol

2. TIAN H, Zhang RX, Zhang D
   A Temporal Paradox in the Proposed Risk-Adjusted Surveillance Algorithm for Metastatic Colorectal Cancer.
   Ann Oncol. 2025 Sep 26:S0923-7534(25)04783-0. doi: 10.1016/j.annonc.2025.
   PubMed        
   
   
3. SALAZAR R, Carmona-Bayonas A
   Toward risk-adjusted CT schedules in first-line metastatic colorectal cancer.
   Ann Oncol. 2025 Sep 23:S0923-7534(25)04780-5. doi: 10.1016/j.annonc.2025.
   PubMed        
   
   

   
   Ann Surg Oncol

4. SCHAFER L, Holzner PA, Menzel M, Stoger GJ, et al
   Iterative Hepatic and Pulmonary Metastasectomy in Stage IV Colorectal Cancer: Impact on Survival and Surgical Outcomes.
   Ann Surg Oncol. 2025 Sep 30. doi: 10.1245/s10434-025-18407.
   PubMed         Abstract available
   
   
5. BRAUNER KB, Mashkoor M, Gogenur M, Lin V, et al
   The Association Between Conducting a Multidisciplinary Team Conference and Short- and Long-Term Outcomes After Colorectal Cancer Surgery: A National Register Study.
   Ann Surg Oncol. 2025 Sep 30. doi: 10.1245/s10434-025-18353.
   PubMed         Abstract available
   
   
6. LADAGE VP, Ramkumar N, Wang Q, O'Malley AJ, et al
   Rurality and Use of Metastasis-Directed Therapies for Medicare Beneficiaries with Metastatic Colon Cancer: A Retrospective Cohort Study.
   Ann Surg Oncol. 2025 Sep 29. doi: 10.1245/s10434-025-18412.
   PubMed         Abstract available
   
   
7. MARINCOLA SMITH P, Lie JJ, Seldomridge A, Galbraith NJ, et al
   Repeat Cytoreductive Surgery for Colorectal Cancer Metastatic to the Peritoneal Cavity.
   Ann Surg Oncol. 2025 Sep 27. doi: 10.1245/s10434-025-18421.
   PubMed         Abstract available
   
   

   
   Anticancer Res

8. TAKAHASHI H, Kojima D, Miyasaka Y, Wada H, et al
   Neoadjuvant Chemotherapy for Initially Resectable Metachronous Colorectal Cancer Liver Metastases Is Associated With Early Postoperative Relapse.
   Anticancer Res. 2025;45:4547-4564.
   PubMed         Abstract available
   
   
9. JIMENEZ PB, Merly AA, Shekouhi R, Demirors B, et al
   Survival Impact and Sociodemographic Correlates of Colon Cancer Surgery Refusal.
   Anticancer Res. 2025;45:4305-4313.
   PubMed         Abstract available
   
   
10. KANG BM, Han Q, Li S, Kim JS, et al
    Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of Cancer.
    Anticancer Res. 2025;45:4193-4200.
    PubMed         Abstract available
    
    
11. FUKATA K, Ogura A, Murata Y, Kobayashi R, et al
    The Impact of Adjuvant Chemotherapy in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemotherapy: A Propensity Score Matching Cohort Study.
    Anticancer Res. 2025;45:4431-4439.
    PubMed         Abstract available
    
    
12. CIFTCI M, Ozgur E, Kulle CB, Gezer U, et al
    Exploring the Clinical Significance of Circulating H19 lncRNA and IGF-2 mRNA in Colorectal Carcinoma.
    Anticancer Res. 2025;45:4243-4251.
    PubMed         Abstract available
    
    
13. HARISI R, Jaray B, Zsirka A, Kulka J, et al
    Differential PCNA Expression Between Neoplastic and Adjacent Mucosa as a Prognostic Marker in Colorectal Adenoma-Carcinoma Progression.
    Anticancer Res. 2025;45:4415-4430.
    PubMed         Abstract available
    
    

    
    BMC Cancer

14. NEMATI M, Dastghaib S, Hosseinzadeh Z, Molayem M, et al
    Importance of PERK pathway modulation on colorectal cancer management: a systematic review.
    BMC Cancer. 2025;25:1502.
    PubMed         Abstract available
    
    
15. ZHENG X, He Y, Tuo Z, Zhu K, et al
    Development of a prognostic risk model for colorectal cancer based on microsatellite stability-associated genes.
    BMC Cancer. 2025;25:1490.
    PubMed         Abstract available
    
    
16. LI SQ, Wang L, Liu XY, Liu XR, et al
    Impact of cardiovascular disease on colorectal cancer morbidity and prognosis.
    BMC Cancer. 2025;25:1448.
    PubMed         Abstract available
    
    
17. WYATT LC, Nguyen CH, LeCroy MN, Foster V, et al
    Prevalence of breast, cervical, and colorectal cancer screenings among select New York City populations.
    BMC Cancer. 2025;25:1469.
    PubMed         Abstract available
    
    
18. WILSON S, Guittet L, Gardy J, Alves A, et al
    Evolution of microsatellite instability testing in a population-based cohort of patients with colorectal cancer in France in the years leading up to official recommendations.
    BMC Cancer. 2025;25:1450.
    PubMed         Abstract available
    
    
19. GOKTAS AYDIN S, Ozguzel B, Bayramova B, Budak E, et al
    Cognitive flexibility, memory, and attention in colorectal cancer: findings from a comprehensive neuropsychological assessment.
    BMC Cancer. 2025;25:1447.
    PubMed         Abstract available
    
    
20. NIEMINEN TT, Kuismin O, Laine R, Lepisto A, et al
    Non-truncating BMPR1A variants associated with familial colorectal cancer and adenomatous polyps.
    BMC Cancer. 2025;25:1435.
    PubMed         Abstract available
    
    

    
    BMC Gastroenterol

21. LIU FQ, He YH, Yan H, Liao JW, et al
    Impact of withdrawal time on the adenoma detection rate in elderly patients during unsedated colonoscopy: a retrospective multicenter study.
    BMC Gastroenterol. 2025;25:660.
    PubMed         Abstract available
    
    
22. CHEN F, Luo D, Jiang X, Chen J, et al
    Disease detected through screening is associated with superior survival outcomes in stage III colorectal cancer: a retrospective study in a Chinese high-volume cancer center.
    BMC Gastroenterol. 2025;25:675.
    PubMed         Abstract available
    
    
23. LI B, Liang Q, Chen Y, Luo W, et al
    Application of colonoscopic auxiliary devices in reducing the polyp miss rate: a prospective randomized controlled study.
    BMC Gastroenterol. 2025;25:684.
    PubMed         Abstract available
    
    

    
    Br J Cancer

24. HOPPENER DJ, Verheul SML, Nierop PMH, Buisman FE, et al
    The colorectal liver metastasis growth pattern phenotype is not dependent on genotype.
    Br J Cancer. 2025;133:945-955.
    PubMed         Abstract available
    
    
25. XIE W, Luo Q, Ou Z, Liu W, et al
    An ABCC1-based risk model is effective in the diagnosis of synchronous peritoneal metastasis in advanced colorectal cancer.
    Br J Cancer. 2025 Sep 26. doi: 10.1038/s41416-025-03203.
    PubMed         Abstract available
    
    

    
    Br J Surg

26. PRATA I, Tanaka MD, Glimelius B, Nagtegaal ID, et al
    Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial.
    Br J Surg. 2025;112:znaf190.
    PubMed         Abstract available
    
    
27. HELLIWELL JA, Chilton CH, Young C, Clark EV, et al
    Perioperative changes in the microbiome during rectal cancer surgery: exploratory analysis of the National Institute for Health and Care Research (NIHR) IntAct trial.
    Br J Surg. 2025;112:znaf199.
    PubMed         Abstract available
    
    

    
    Cancer Lett

28. YIN Z, Zhou Y, Zhu X, Goettl RA, et al
    Cancer-associated fibroblast secreted DKK1 promotes the immunosuppressive tumor microenvironment and colorectal cancer resistance to chemotherapy.
    Cancer Lett. 2025 Sep 24:218060. doi: 10.1016/j.canlet.2025.218060.
    PubMed         Abstract available
    
    
29. BAI M, Li N, Yin X, Huang C, et al
    An anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) and chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer: A phase Ib study.
    Cancer Lett. 2025 Sep 24:218061. doi: 10.1016/j.canlet.2025.218061.
    PubMed         Abstract available
    
    

    
    Cancer Res

30. ZHOU M, Liu H, Hui J, Chen Q, et al
    Extracellular Vesicle-Packaged miR-99a Reprograms Fibroblasts to Create an Inflammatory Niche that Drives Colorectal Cancer Metastasis.
    Cancer Res. 2025 Sep 24. doi: 10.1158/0008-5472.CAN-25-0663.
    PubMed         Abstract available
    
    
31. MODL B, Zwolanek D, Schwertner K, Krauss D, et al
    TYK2 Promotes Immunosurveillance of Colorectal Cancer Liver Metastasis.
    Cancer Res. 2025 Sep 24. doi: 10.1158/0008-5472.CAN-24-4224.
    PubMed         Abstract available
    
    
32. SCHATTON D, Frezza C
    Alternatively Spliced Citrate Synthase Supports Colorectal Cancer.
    Cancer Res. 2025 Oct 1:OF1-OF3. doi: 10.1158/0008-5472.CAN-25-3356.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

33. BALLHAUSEN A, Swoboda S, Horst D, Fruehauf S, et al
    Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti-EGFR-Based Maintenance for RAS wt Metastatic CRC-The PanaMa (AIO KRK0212) Trial.
    Clin Cancer Res. 2025;31:4049-4058.
    PubMed         Abstract available
    
    

    
    Clin Res Hepatol Gastroenterol

34. KANG D, Li J, Xu J, Li Y, et al
    Clinical application value of MYO1-G methylation in plasma circulating tumor DNA combined with fecal occult blood test for early screening of colorectal cancer.
    Clin Res Hepatol Gastroenterol. 2025 Sep 22:102690.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

35. SAHIN A
    Integrating ctDNA and iRECIST to Guide Surgery After Immunotherapy in MSI-H Colorectal Cancer.
    Dis Colon Rectum. 2025 Sep 30. doi: 10.1097/DCR.0000000000003981.
    PubMed        
    
    

    
    Eur J Cancer

36. BERGEN ES, Le Malicot K, Taieb J
    Response to letter Re: Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients - A post-hoc analysis of the PETACC 8 trial.
    Eur J Cancer. 2025;230:115798.
    PubMed        
    
    
37. ONDER AH, Catli MM
    Colorectal cancer treatment commentary review.
    Eur J Cancer. 2025;230:115809.
    PubMed         Abstract available
    
    
38. LIU J, Yang S, Zhang G
    Letter Re: Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients - A post-hoc analysis of the PETACC 8 trial.
    Eur J Cancer. 2025;230:115797.
    PubMed        
    
    
39. KIM Y, Kim EY, Kim MY, Cho BH, et al
    Immune-enhanced machine learning approach for early detection of precancerous colorectal neoplasia: Insights from biomarkers in routine health checkups.
    Eur J Cancer. 2025;229:115786.
    PubMed         Abstract available
    
    

    
    Eur J Gastroenterol Hepatol

40. KARNIADAKIS I, Papadakos SP, Argyroy A, Syllaios A, et al
    Comparative efficacy and safety of endoscopic submucosal dissection versus transanal endoscopic microsurgery for the treatment of rectal polyps: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2025;37:1191-1197.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

41. GU YC, Yang M, Geng Y, Zhang B, et al
    Tumor-Boundary Response Index (TBRI)- A promising indicator for predicting outcomes in colorectal liver metastases receiving neoadjuvant therapy: Insights from a single-center retrospective study.
    Eur J Surg Oncol. 2025;51:110291.
    PubMed         Abstract available
    
    
42. BEN HMIDO S, Abder Rahim H, Ingwersen EW, Burchell G, et al
    Transparency in Externally Validated Models: A systematic review of machine learning vs. logistic regression for predicting colorectal anastomotic leakage.
    Eur J Surg Oncol. 2025;51:110367.
    PubMed         Abstract available
    
    
43. GOBARDHAN PD, Veen EJ, Rijken AM, Ayez N, et al
    Video-assisted total transthoracic liver resection for colorectal liver metastasis, safety and feasibility.
    Eur J Surg Oncol. 2025;51:110389.
    PubMed         Abstract available
    
    
44. KANG B, Qiao Y, Song J, Zhang Z, et al
    Interpretable machine learning model for predicting perioperative Clavien-Dindo III/IV complications of rectal cancer anterior resection after neoadjuvant therapy: a real-world study.
    Eur J Surg Oncol. 2025;51:110365.
    PubMed         Abstract available
    
    
45. NAESSENS C, Evin C, Le-Malicot K, Lemanski C, et al
    Salvage abdominoperineal resection for anal squamous cell carcinoma after radiotherapy or chemoradiotherapy: analysis of the French prospective cohort FFCD-ANABASE.
    Eur J Surg Oncol. 2025;51:110346.
    PubMed         Abstract available
    
    
46. GOULD LE, Pring ET, Wallace A, Hodges N, et al
    Clinical determinants of outcome following pelvic exenteration for locally advanced or locally recurrent rectal cancer.
    Eur J Surg Oncol. 2025;51:110347.
    PubMed         Abstract available
    
    
47. WANG Z, Liu Q
    A retrospective analysis of 44 diminutive rectal neuroendocrine neoplasms that were not suitable for local treatment.
    Eur J Surg Oncol. 2025;51:110348.
    PubMed         Abstract available
    
    
48. HOANG VM, Turner B, Ho R, Tucker J, et al
    The impact of colorectal cancer diagnosis and treatment on quality of life is increased in young patients.
    Eur J Surg Oncol. 2025;51:110483.
    PubMed         Abstract available
    
    
49. ZHOU Y, Zhao J, Tan Y, Zou F, et al
    CT-based radiomics deep learning signatures for noninvasive prediction of early recurrence after radical surgery in locally advanced colorectal cancer: A multicenter study.
    Eur J Surg Oncol. 2025;51:110482.
    PubMed         Abstract available
    
    
50. EMILE SH, Horesh N, Garoufalia Z, Wignakumar A, et al
    Association between the type of pre-existing adenoma and response of rectal cancer to neoadjuvant therapy.
    Eur J Surg Oncol. 2025;51:110319.
    PubMed         Abstract available
    
    
51. WILLIAMS T, Hayler R, Garrett C, Barat S, et al
    Impact of diaphragmatic intervention in cytoreductive surgery with heated intraperitoneal chemotherapy for colorectal carcinoma.
    Eur J Surg Oncol. 2025;51:110306.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

52. DEKKERS N, Kruizinga MD, Dang H, Stuurman FE, et al
    Physical recovery after local resection of nonpedunculated rectal adenomas and T1 carcinomas: endoscopic submucosal dissection versus transanal minimally invasive surgery.
    Gastrointest Endosc. 2025;102:583-592.
    PubMed         Abstract available
    
    

    
    Int J Cancer

53. VAN ERNING FN, Galanos LJK, Lurvink R, Aarts MJ, et al
    Socioeconomic differences among patients with stage I-III colon cancer: Detection, treatment and relative survival.
    Int J Cancer. 2025 Oct 2. doi: 10.1002/ijc.70181.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

54. CHEN B, Peng T, Pan Z, Li S, et al
    Development and validation of machine-learning model based on dynamic tumor markers in predicting pathological complete response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a multicenter cohort study.
    Int J Colorectal Dis. 2025;40:204.
    PubMed         Abstract available
    
    
55. LI Y, Xiong H, Liang T, Liu Y, et al
    Missed colorectal cancer diagnosis by screening colonoscopy based on the PLCO cancer screening trial.
    Int J Colorectal Dis. 2025;40:206.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

56. CHEN L, Wang Y, Cai C, Ding Y, et al
    Erratum: Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer.
    J Clin Oncol. 2025 Oct 2:JCO2502281. doi: 10.1200/JCO-25-02281.
    PubMed        
    
    

    
    J Natl Cancer Inst

57. EBNER DW, Estes C, Limburg PJ
    RE: Evaluating benefit-to-burden ratios of the established and emerging colorectal cancer screening strategies.
    J Natl Cancer Inst. 2025 Oct 1:djaf266. doi: 10.1093.
    PubMed        
    
    
58. CHENG E, Shi Q, Shields AF, Xue X, et al
    Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (alliance).
    J Natl Cancer Inst. 2025 Sep 25:djaf281. doi: 10.1093.
    PubMed         Abstract available
    
    
59. EBNER DW, Fendrick AM, Kisiel JB, Estes C, et al
    Evaluating benefit-to-burden ratios of the established and emerging colorectal cancer screening strategies.
    J Natl Cancer Inst. 2025 Oct 1:djaf209. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Nucl Med

60. KUJAWSKI M, Aniogo E, Wong P, Hui S, et al
    Combination Image-Guided and Antibody-Targeted alpha-Therapy Before Targeted Immunotherapy for Treatment of Solid Tumors.
    J Nucl Med. 2025;66:1605-1611.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

61. FILHO MO, Lenzi MC, de Lima PEC, Amaral MA, et al
    Redefining Precision: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Robotic-Assisted Versus Laparoscopic Surgery in Colorectal Cancer.
    J Surg Oncol. 2025 Sep 29. doi: 10.1002/jso.70098.
    PubMed         Abstract available
    
    

    
    Oncogene

62. LANZLOTH R, Harris NL, Cannon AM, Kaplan MH, et al
    Mast cells interact directly with colorectal cancer cells to promote epithelial-to-mesenchymal transition.
    Oncogene. 2025 Oct 2. doi: 10.1038/s41388-025-03589.
    PubMed         Abstract available
    
    

    
    Oncol Rep

63. CHENG J, Yang X, Zhao W, Xu J, et al
    REV1?targeting inhibitor JH?RE?06 induces ferroptosis via NCOA4?mediated ferritinophagy in colorectal cancer cells.
    Oncol Rep. 2025;54:159.
    PubMed         Abstract available
    
    
64. WANG G, Yu Y, Wang YZ, Zhu ZM, et al
    [Retracted] Effects and mechanisms of fatty acid metabolism?mediated glycolysis regulated by betulinic acid?loaded nanoliposomes in colorectal cancer.
    Oncol Rep. 2025;54:161.
    PubMed         Abstract available
    
    

    
    PLoS One

65. KWAO-ZIGAH G, Bediako-Bowan A, Atampugbire GA, Kwayisi-Darkwah CK, et al
    Association of serum intestinal fatty-acid binding protein, inflammatory and oxidative stress markers with colorectal cancer among Ghanaian patients.
    PLoS One. 2025;20:e0333799.
    PubMed         Abstract available
    
    
66. WU W, Mols F, Bonhof CS, Maas L, et al
    Association of ageing-related biomarkers with peripheral neuropathy in colorectal cancer patients up to 2 years after diagnosis.
    PLoS One. 2025;20:e0332579.
    PubMed         Abstract available
    
    
67. YUAN W, Liu L
    Immune subtyping of lymph node metastasis-negative colorectal cancer reveals biomarkers for prognosis and immunotherapy response.
    PLoS One. 2025;20:e0332915.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.